Results 101 to 110 of about 127,263 (196)

Glucagon-Like Peptide-1 Targets in the Human Nodose Ganglion. [PDF]

open access: yesJ Comp Neurol
Merchant W   +3 more
europepmc   +1 more source

Administrative costs of prior authorizations for glucagon-like peptide-1 agonists. [PDF]

open access: yesJ Manag Care Spec Pharm
Pham D   +6 more
europepmc   +1 more source

Impact of GLP-1 Receptor Agonists on Perceived Eating Behaviors in Response to Stimuli

open access: yesDiabetes, Metabolic Syndrome and Obesity
Carol Cheney,1 Krystal Hunter,1 Marlena Klein2 1Cooper Medical School of Rowan University, Camden, NJ, USA; 2Internal Medicine Department, Cooper University Hospital, Camden, NJ, USACorrespondence: Carol Cheney, Cooper Medical School of Rowan University,
Cheney C, Hunter K, Klein M
doaj  

Interactions of a Glucagon-like peptide 1 and a Glucagon-like peptide 1 analogue, liraglutide, with the endogenous receptor [PDF]

open access: yes, 2015
Bukrinski, Jens T.   +3 more
core  

Oral Glucagon-Like Peptide-1 Receptor Agonists for Preventing Cardiorenal Complications. [PDF]

open access: yesCurr Cardiol Rep
Odeleye V   +6 more
europepmc   +1 more source

Distribution of glucagon-like peptide 1 receptor and insulin in phaeochromocytomas. [PDF]

open access: yesEndocr Connect
Følling I   +5 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists in Obesity-Induced Respiratory Pathophysiology. [PDF]

open access: yesActa Physiol (Oxf)
Ruiz MA   +5 more
europepmc   +1 more source

Prescribing Trends in Glucagon-Like Peptide-1 Medications Among Pregnant and Postpartum Persons. [PDF]

open access: yesObstet Gynecol
Lessard C   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy